JP5025535B2 - Antibacterial agent composition and deodorant composition - Google Patents
Antibacterial agent composition and deodorant composition Download PDFInfo
- Publication number
- JP5025535B2 JP5025535B2 JP2008068634A JP2008068634A JP5025535B2 JP 5025535 B2 JP5025535 B2 JP 5025535B2 JP 2008068634 A JP2008068634 A JP 2008068634A JP 2008068634 A JP2008068634 A JP 2008068634A JP 5025535 B2 JP5025535 B2 JP 5025535B2
- Authority
- JP
- Japan
- Prior art keywords
- deodorant
- composition
- antibacterial
- antibacterial agent
- triclosan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims description 51
- 239000002781 deodorant agent Substances 0.000 title claims description 40
- 239000003242 anti bacterial agent Substances 0.000 title claims description 13
- 230000000844 anti-bacterial effect Effects 0.000 claims description 30
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 claims description 18
- 229960003500 triclosan Drugs 0.000 claims description 16
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 claims description 11
- 241000894006 Bacteria Species 0.000 claims description 11
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 claims description 11
- 229950002760 sodium gualenate Drugs 0.000 claims description 7
- 230000001166 anti-perspirative effect Effects 0.000 claims description 4
- 239000003213 antiperspirant Substances 0.000 claims description 4
- VIZXMHCBZLGUET-UHFFFAOYSA-N sodium gualenate Chemical compound CC(C)C1=CC=C(C)C2=C(S(O)(=O)=O)C=C(C)C2=C1 VIZXMHCBZLGUET-UHFFFAOYSA-N 0.000 claims description 2
- GEYJUFBPCGDENK-UHFFFAOYSA-M sodium;3,8-dimethyl-5-propan-2-ylazulene-1-sulfonate Chemical compound [Na+].CC(C)C1=CC=C(C)C2=C(S([O-])(=O)=O)C=C(C)C2=C1 GEYJUFBPCGDENK-UHFFFAOYSA-M 0.000 description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- 210000002374 sebum Anatomy 0.000 description 13
- -1 chlorohydroxyaluminum Chemical compound 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 238000002156 mixing Methods 0.000 description 10
- 210000004243 sweat Anatomy 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 8
- 230000001877 deodorizing effect Effects 0.000 description 8
- 235000019645 odor Nutrition 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- NTOPKICPEQUPPH-UHFFFAOYSA-N IPMP Natural products COC1=NC=CN=C1C(C)C NTOPKICPEQUPPH-UHFFFAOYSA-N 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 239000002304 perfume Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- FWKQNCXZGNBPFD-UHFFFAOYSA-N Guaiazulene Chemical compound CC(C)C1=CC=C(C)C2=CC=C(C)C2=C1 FWKQNCXZGNBPFD-UHFFFAOYSA-N 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 241000186216 Corynebacterium Species 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- 241000191963 Staphylococcus epidermidis Species 0.000 description 3
- BAECOWNUKCLBPZ-HIUWNOOHSA-N Triolein Natural products O([C@H](OCC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCC/C=C\CCCCCCCC)C(=O)CCCCCCC/C=C\CCCCCCCC BAECOWNUKCLBPZ-HIUWNOOHSA-N 0.000 description 3
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 3
- 229940117972 triolein Drugs 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 208000035985 Body Odor Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 206010040904 Skin odour abnormal Diseases 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 230000000873 masking effect Effects 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 239000003352 sequestering agent Substances 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- ZNVKGUVDRSSWHV-UHFFFAOYSA-L zinc;4-hydroxybenzenesulfonate Chemical compound [Zn+2].OC1=CC=C(S([O-])(=O)=O)C=C1.OC1=CC=C(S([O-])(=O)=O)C=C1 ZNVKGUVDRSSWHV-UHFFFAOYSA-L 0.000 description 2
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 229940031723 1,2-octanediol Drugs 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- FEPBITJSIHRMRT-UHFFFAOYSA-N 4-hydroxybenzenesulfonic acid Chemical compound OC1=CC=C(S(O)(=O)=O)C=C1 FEPBITJSIHRMRT-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- HDYRYUINDGQKMC-UHFFFAOYSA-M acetyloxyaluminum;dihydrate Chemical compound O.O.CC(=O)O[Al] HDYRYUINDGQKMC-UHFFFAOYSA-M 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- 229940009827 aluminum acetate Drugs 0.000 description 1
- 229940063656 aluminum chloride Drugs 0.000 description 1
- 229940103272 aluminum potassium sulfate Drugs 0.000 description 1
- 229940010048 aluminum sulfate Drugs 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229910052586 apatite Inorganic materials 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- KKEMWYNNTBRYMR-UHFFFAOYSA-N azulene-1-sulfonic acid Chemical compound C1=CC=CC=C2C(S(=O)(=O)O)=CC=C21 KKEMWYNNTBRYMR-UHFFFAOYSA-N 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- YSRSBDQINUMTIF-UHFFFAOYSA-N decane-1,2-diol Chemical compound CCCCCCCCC(O)CO YSRSBDQINUMTIF-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940009662 edetate Drugs 0.000 description 1
- 230000002289 effect on microbe Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 229960002350 guaiazulen Drugs 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- ULYZAYCEDJDHCC-UHFFFAOYSA-N isopropyl chloride Chemical compound CC(C)Cl ULYZAYCEDJDHCC-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- RLSSMJSEOOYNOY-UHFFFAOYSA-N m-cresol Chemical compound CC1=CC=CC(O)=C1 RLSSMJSEOOYNOY-UHFFFAOYSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229940100630 metacresol Drugs 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
本発明は抗菌剤組成物、並びに該抗菌剤組成物を含有した防臭剤用組成物に関する。 The present invention relates to an antibacterial agent composition and a composition for a deodorant containing the antibacterial agent composition.
人に不快感を与える腋臭などの体臭は、特に、汗が皮脂と混ざり、それが腋臭原因菌により分解されることにより生じるとされている。 It is said that body odor such as odor that gives a person unpleasant feeling is caused by sweat mixed with sebum, which is decomposed by odor-causing bacteria.
そこで、従来から、体臭の発生を抑制するために、抗菌性化合物が防臭剤用組成物に用いられてきた(例えば、特許文献1〜3を参照)。 Therefore, in order to suppress the generation of body odor, antibacterial compounds have been conventionally used in deodorant compositions (see, for example, Patent Documents 1 to 3).
しかし、人の肌には汗腺や皮脂腺が存在し、その時々で汗と皮脂の量が異なり、汗(水分)が多い状態と皮脂が多い状態とでは、抗菌性化合物の抗菌活性が異なる可能性があった。従来の防臭剤用組成物では、このような肌状態の変化に対応できず、防臭・消臭効果を十分に発揮できないといった問題があった。さらには、肌状態の変化により、防臭・消臭効果が持続して得られないといった問題もあった。 However, there are sweat glands and sebaceous glands in human skin, and the amount of sweat and sebum varies from time to time, and the antibacterial activity of antibacterial compounds may differ between the state where there is a lot of sweat (moisture) and the amount of sebum was there. Conventional deodorant compositions cannot cope with such changes in skin condition, and have a problem in that the deodorant / deodorant effect cannot be sufficiently exhibited. Furthermore, there has been a problem that the deodorizing / deodorizing effect cannot be obtained continuously due to changes in the skin condition.
一方、トリクロサン及びイソプロピルメチルフェノールを併用することにより、汗が多く分泌した肌状態に加え、皮脂が多く分泌した肌状態でも、腋臭原因菌に対する抗菌活性を維持できるデオドラント剤が報告されている(特許文献4を参照)。 On the other hand, by using triclosan and isopropylmethylphenol in combination, a deodorant agent has been reported that can maintain antibacterial activity against odor-causing bacteria even in a skin state that secretes a lot of sebum in addition to a skin state that secretes a lot of sweat (patent) (Ref. 4).
しかし、上記技術では、異なった肌状態でも腋臭原因菌に対する抗菌活性を維持できることに留まり、抗菌活性を相乗的に増強できるものではなかった。そこで、種々の肌状態でも、より効果的に防臭・消臭効果を発揮できる防臭剤用組成物の開発が望まれる。 However, the above-described technology has been limited to the ability to maintain antibacterial activity against odor-causing bacteria even in different skin conditions, and has not been able to synergistically enhance antibacterial activity. Therefore, development of a composition for a deodorant capable of exhibiting a deodorizing / deodorizing effect more effectively even in various skin conditions is desired.
本発明は、上記従来技術に鑑みてなされたものであって、アズレンスルホン酸塩と併用することで、汗や皮脂の量や比率が異なる様々な肌状態でも、トリクロサン又はイソプロピルメチルフェノールが有する抗菌活性を増強できる抗菌剤組成物、並びに該抗菌剤組成物を含有してなる防臭剤用組成物を提供することを課題とする。 The present invention has been made in view of the above prior art, and is used in combination with azulene sulfonate, so that triclosan or isopropylmethylphenol has antibacterial properties even in various skin conditions with different amounts and ratios of sweat and sebum. It is an object of the present invention to provide an antibacterial composition capable of enhancing the activity, and a composition for a deodorant containing the antibacterial composition.
すなわち、本発明は、
〔1〕アズレンスルホン酸塩と、トリクロサン及び/又はイソプロピルメチルフェノールとを含有することを特徴とする抗菌剤組成物、並びに
〔2〕前記〔1〕に記載の抗菌剤組成物を含有してなる防臭剤用組成物
に関する。
That is, the present invention
[1] An antibacterial agent composition containing azulene sulfonate, triclosan and / or isopropylmethylphenol, and [2] an antibacterial agent composition described in [1] above. The present invention relates to a deodorant composition.
本発明にかかる抗菌剤組成物は、アズレンスルホン酸塩と併用することで、汗や皮脂の量や比率が異なる様々な肌状態でも、トリクロサン又はイソプロピルメチルフェノールが本来有する抗菌活性を増強することができるという効果を奏する。 The antibacterial agent composition according to the present invention can enhance the antibacterial activity inherent to triclosan or isopropylmethylphenol even in various skin conditions with different amounts and ratios of sweat and sebum when used in combination with azulene sulfonate. There is an effect that can be done.
また、本発明にかかる抗菌剤組成物は、様々な肌状態で腋臭原因菌に対して優れた抗菌活性を発揮することから、該組成物を含有した防臭剤組成物は、優れた防臭効果を発揮する。 In addition, since the antibacterial agent composition according to the present invention exhibits excellent antibacterial activity against odor-causing bacteria in various skin conditions, the deodorant composition containing the composition has an excellent deodorizing effect. Demonstrate.
本発明にかかる抗菌剤組成物は、必須成分としてアズレンスルホン酸塩と、トリクロサン及び/又はイソプロピルメチルフェノールとを含有する。 The antibacterial agent composition according to the present invention contains azulene sulfonate and triclosan and / or isopropylmethylphenol as essential components.
アズレンスルホン酸塩は、グアイアズレン(7−イソプロピル−1,4−ジメチルアズレン)のスルホン酸塩であり、抗炎症作用を有する物質である。水溶性アズレンや、グアイアズレンスルホン酸塩とも称される。 Azulene sulfonate is a sulfonate of guaiazulene (7-isopropyl-1,4-dimethylazulene) and is a substance having an anti-inflammatory action. Also called water-soluble azulene or guaiazulene sulfonate.
アズレンスルホン酸の塩は、特に限定されないが、ナトリウム塩、カリウム塩、アンモニウム塩などを例示することができ、ナトリウム塩を用いるのが好ましい。 The salt of azulene sulfonic acid is not particularly limited, and examples thereof include sodium salts, potassium salts, ammonium salts, and the use of sodium salts is preferred.
トリクロサンは、トリクロロヒドロキシジフェニルエーテルであり、広範囲の抗菌スペクトルをもつ殺菌剤である。 Triclosan is trichlorohydroxydiphenyl ether and is a fungicide with a broad antibacterial spectrum.
イソプロピルメチルフェノール(以下、IPMPと略す。)は、メタクレゾールとイソプロピルクロリド、或いはイソプロピルアルコールとを反応させて得られ、殺菌性と弱い収斂性を持つ殺菌剤である。 Isopropylmethylphenol (hereinafter abbreviated as IPMP) is a bactericidal agent obtained by reacting metacresol and isopropyl chloride or isopropyl alcohol and having bactericidal properties and weak astringency.
本発明にかかる抗菌剤組成物は、第一の成分であるアズレンスルホン酸塩と、第二の成分であるトリクロサン及び/又はIPMPの含有量は特に限定されないが、好ましくは、重量比で0.1:1〜10:1、より好ましくは0.2:1〜5:1、更に好ましくは0.5:1〜2:1となるように配合する。第一の成分の含有量が第二の成分の10重量部を超えて配合すると、また、0.1重量部未満の場合、抗菌活性の増強効果が期待できないために好ましくない。 In the antibacterial agent composition according to the present invention, the contents of the first component, azulene sulfonate, and the second component, triclosan and / or IPMP, are not particularly limited. The blending ratio is 1: 1 to 10: 1, more preferably 0.2: 1 to 5: 1, and still more preferably 0.5: 1 to 2: 1. When the content of the first component exceeds 10 parts by weight of the second component, and less than 0.1 parts by weight, the antibacterial activity enhancing effect cannot be expected, which is not preferable.
尚、本発明の抗菌剤組成物には、第一の成分及び第二の成分の他、本発明の効果を阻害しない範囲で、溶剤、界面活性剤、酸化防止剤、金属イオン封鎖剤等を適宜配合することができる。 In addition to the first component and the second component, the antibacterial agent composition of the present invention includes a solvent, a surfactant, an antioxidant, a sequestering agent, etc., as long as the effects of the present invention are not impaired. It can mix | blend suitably.
本発明の抗菌剤組成物は、防臭剤用組成物に配合して使用することができる。その配合量は、特に限定されないが、防臭剤用組成物中0.001〜3重量%、好ましくは0.01〜2重量%、より好ましくは0.1〜1重量%とするとよい。配合量が0.001重量%未満の場合、抗菌効果に劣るために、また、3重量%を超えて配合すると、皮膚刺激性など安全性に問題が生じる場合があるために、いずれの場合も好ましくない。 The antibacterial agent composition of the present invention can be used by blending with a deodorant composition. Although the compounding quantity is not specifically limited, 0.001 to 3 weight% in a composition for deodorants, Preferably it is 0.01 to 2 weight%, More preferably, it is good to set it as 0.1 to 1 weight%. When the blending amount is less than 0.001% by weight, the antibacterial effect is inferior. When the blending amount exceeds 3% by weight, there may be a problem in safety such as skin irritation. It is not preferable.
また、本発明の防臭剤用組成物には、更に、制汗成分や消臭成分を配合することができる。 Moreover, an antiperspirant component and a deodorant component can be further mix | blended with the composition for deodorizers of this invention.
制汗成分とは、皮膚を収斂することにより汗の発生を抑制する薬剤であり、例えば、塩化アルミニウム、硫酸アルミニウムカリウム、硫酸アルミニウム、酢酸アルミニウム、クロロヒドロキシアルミニウム、アラントインクロロヒドロキシアルミニウム、パラフェノールスルホン酸亜鉛などを例示することができる。 Antiperspirant component is a drug that suppresses the generation of sweat by converging the skin. For example, aluminum chloride, aluminum potassium sulfate, aluminum sulfate, aluminum acetate, chlorohydroxyaluminum, allantoin chlorohydroxyaluminum, paraphenolsulfonic acid Zinc and the like can be exemplified.
制汗成分の配合量は、本発明の効果を発揮すれば特に限定されず、デオドラント剤中0.1〜20重量%とするのが好ましく、0.3〜15重量%とすることがより好ましい。0.1重量%未満の配合量では、防臭・消臭効果の持続性に劣るために、また、20重量%を超えて配合すると、皮膚刺激性など安全性に問題が生じる場合があるために、いずれの場合も好ましくない。 The blending amount of the antiperspirant component is not particularly limited as long as the effect of the present invention is exerted, and is preferably 0.1 to 20% by weight, more preferably 0.3 to 15% by weight in the deodorant agent. . If the blending amount is less than 0.1% by weight, the durability of the deodorizing / deodorizing effect is inferior. If the blending amount exceeds 20% by weight, safety problems such as skin irritation may occur. In either case, it is not preferable.
消臭成分とは、臭いを発する物質と反応・吸着したり、臭いをマスクしたりして、臭いを消す効果を有する薬剤であり、例えば、酸化亜鉛などの金属酸化物、アルキルジエタノールアミド、ヒドロキシアパタイト、茶抽出物、香料、酸化防止剤などを例示することができる。 A deodorant component is a chemical that has the effect of eliminating odors by reacting and adsorbing substances that emit odors or masking odors. For example, metal oxides such as zinc oxide, alkyldiethanolamide, hydroxy Examples include apatite, tea extract, fragrance, and antioxidant.
消臭成分の配合量は、本発明の効果を発揮すれば特に限定されず、防臭剤用組成物中0.01〜5重量%とするのが好ましく、0.1〜2重量%とすることがより好ましい。0.01重量%未満の配合量では、臭いのマスキングの効果に劣るために、また、5重量%を超えて配合すると、香りが強くなりすぎたり、肌への着色が生ずる場合があり、また、皮膚刺激性など安全性に問題が生じる場合があるために、いずれの場合も好ましくない。 The blending amount of the deodorant component is not particularly limited as long as the effect of the present invention is exhibited, and is preferably 0.01 to 5% by weight, and preferably 0.1 to 2% by weight in the composition for deodorant. Is more preferable. If the blending amount is less than 0.01% by weight, the effect of masking the odor is inferior. If the blending amount exceeds 5% by weight, the scent may become too strong or the skin may be colored. In any case, it is not preferable because safety problems such as skin irritation may occur.
本発明の防臭剤用組成物には、本発明の効果を阻害しない範囲で、上記した成分の他、エタノール、イソプロピルアルコール等の低級アルコール;ラウリルアルコール、ステアリルアルコール等の高級アルコール;グリセリン、ジグリセリン、ジプロピレングリコール、1,3−ブタンジオール、1,2−ペンタンジオール、1,2−ヘキサンジオール、1,2−オクタンジオール、1,2−デカンジオール等の多価アルコール;ベントナイト、カラギーナン、カルボキシビニルポリマー、ヒドロキシエチルセルロース等の増粘剤;トコフェロール及びその誘導体、アスコルビン酸及びその誘導体等の酸化防止剤;エデト酸塩、リン酸、ポリリン酸ナトリウム等の金属イオン封鎖剤;動物及び植物エキス、クエン酸、酒石酸等のpH調整剤;シリコーン類、保湿剤、界面活性剤、防腐剤、粉体、着色剤、水等を適宜配合することもできる。 The deodorant composition of the present invention includes, in the range not inhibiting the effects of the present invention, lower alcohols such as ethanol and isopropyl alcohol; higher alcohols such as lauryl alcohol and stearyl alcohol; glycerin and diglycerin. Polyhydric alcohols such as dipropylene glycol, 1,3-butanediol, 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, 1,2-decanediol; bentonite, carrageenan, carboxy Thickeners such as vinyl polymer and hydroxyethyl cellulose; antioxidants such as tocopherol and its derivatives, ascorbic acid and its derivatives; sequestering agents such as edetate, phosphoric acid and sodium polyphosphate; animal and plant extracts, citrus PH adjusters such as acid and tartaric acid; Recone acids, humectants, surfactants, preservatives, powders, coloring agents, can also be appropriately blended and water.
本発明の防臭剤用組成物は、腋臭原因菌に対して優れた抗菌活性を発揮することから、靴やブーツ用の防臭・消臭剤、足や腋下の防臭・消臭剤などに用いることができる。なかでも、汗と皮脂の量の異なる様々な肌状態でも優れた抗菌活性を発揮することから、足、腋下などの身体用の防臭・消臭剤として好ましく用いることができる。 Since the composition for deodorant of the present invention exhibits excellent antibacterial activity against the odor-causing bacteria, it is used as a deodorant / deodorant for shoes and boots, a deodorant / deodorant for feet and underarms, etc. be able to. Among them, since it exhibits excellent antibacterial activity even in various skin conditions with different amounts of sweat and sebum, it can be preferably used as a deodorant / deodorant for the body of feet, armpits and the like.
また、その剤型は、ローション、エアゾール、スティック、パウダー、ロールオン、クリーム、ジェル、乳液、シート剤などの種々の形態で用いることができ、製剤化については、一般に知られている方法により製造すればよい。 In addition, the dosage form can be used in various forms such as lotion, aerosol, stick, powder, roll-on, cream, gel, emulsion, sheet, etc., and the formulation can be produced by a generally known method. That's fine.
<試験例1>
供試菌として、 腋臭原因菌である、スタフィロコッカス エピデルミディス(Staphylococcus epidermidis IAM1296)及びコリネバクテリウム ミヌティシマム(Corynebacterium minutissimum ATCC23348)を用いた。
<Test Example 1>
As test bacteria, Staphylococcus epidermidis IAM1296 and Corynebacterium minutisium ATCC23348, which are odor-causing bacteria, were used.
(接種菌液の調製)
接種用菌液としてスタフィロコッカス エピデルミディス又はコリネバクテリウム ミヌティシマムを寒天培地で35℃で培養後、更にブイヨン培地に移植して35℃で培養した。得られた培養液をブイヨン培地で約107個/mLに希釈したものを接種用菌液とした。
(Preparation of inoculum solution)
Staphylococcus epidermidis or Corynebacterium minutishimam was cultured at 35 ° C. on an agar medium as an inoculum and then transplanted to a bouillon medium and cultured at 35 ° C. A solution obtained by diluting the obtained culture solution with a bouillon medium to about 10 7 cells / mL was used as a bacterial solution for inoculation.
(希釈系列の調製)
アズレンスルホン酸ナトリウム(比較例1)、トリクロサン(比較例2)、及びIPMP(比較例3)は、70%エタノールを希釈溶媒として3000μg/mLに調製し、10段階に倍倍希釈して希釈系列を調製した。
(Preparation of dilution series)
Sodium azulenesulfonate (Comparative Example 1), Triclosan (Comparative Example 2), and IPMP (Comparative Example 3) were prepared to 3000 μg / mL using 70% ethanol as a diluent solvent, and diluted 10-fold to a dilution series. Was prepared.
また、アズレンスルホン酸ナトリウムとトリクロサンの等量混合物(実施例1)、及びアズレンスルホン酸ナトリウムとIPMPの等量混合物(実施例2)についても、同様に希釈系列を調製した。 In addition, dilution series were similarly prepared for an equivalent mixture of sodium azulenesulfonate and triclosan (Example 1) and an equivalent mixture of sodium azulenesulfonate and IPMP (Example 2).
(最小殺菌濃度(MBC)の測定)
上記の各被験物質を含む希釈系列1mLに対して各寒天培地9mLをシャーレに入れ、それぞれについて、上記接種用菌液を約1cmの長さに画線した。培養は、35℃で行い5日後の菌の生育の有無を判定した。このとき、生育が認められなかった濃度では、接種した画線から菌を採取し、新鮮寒天培地に移植し更に3日培養した。このとき、生育が認められなかった最小の濃度をMBCとして求め、そのときの各成分の濃度を表1〜4(トレオレイン非添加)に記した。
(Measurement of minimum bactericidal concentration (MBC))
For each 1 mL of the dilution series containing each test substance, 9 mL of each agar medium was placed in a petri dish. Culturing was performed at 35 ° C., and the presence or absence of bacterial growth after 5 days was determined. At a concentration at which no growth was observed at this time, the bacteria were collected from the inoculated streak, transplanted to a fresh agar medium, and further cultured for 3 days. At this time, the minimum concentration at which no growth was observed was determined as MBC, and the concentration of each component at that time was shown in Tables 1 to 4 (no addition of treolein).
(皮脂成分の影響の検討)
皮脂成分の影響による殺菌効果を検討するために、皮脂成分としてトレオレインを添加して下記試験を実施した。即ち、上記各被験物質を含む希釈系列1mLに対して、0.5重量%のトリオレインと寒天培地8.5mLをシャーレに入れ、それぞれについて、上記と同様に接種用菌液を約1cmの長さに画線した。培養は、35℃で行い5日後の菌の生育の有無を判定した。このとき、生育が認められなかった濃度では、接種した画線から菌を採取し、新鮮寒天培地に移植しさらに3日培養した。このとき、生育が認められなかった最小の濃度をMBCとして求め、そのときの各成分の濃度を表1〜4(トレオレイン添加)に記した。
(Examination of the effects of sebum components)
In order to examine the bactericidal effect due to the influence of sebum components, treolein was added as a sebum component and the following test was performed. That is, for each 1 mL of the dilution series containing each test substance, 0.5% by weight of triolein and 8.5 mL of agar medium were placed in a petri dish. I streaked. Culturing was performed at 35 ° C., and the presence or absence of bacterial growth after 5 days was determined. At a concentration at which no growth was observed at this time, the bacteria were collected from the inoculated streak, transplanted to a fresh agar medium, and further cultured for 3 days. At this time, the minimum concentration at which no growth was observed was determined as MBC, and the concentration of each component at that time was shown in Tables 1 to 4 (added with treolein).
尚、表1〜2はスタフィロコッカス エピデルミディスに関し、また、表3〜4はコリネバクテリウム ミヌティシマムに関する結果である。 Tables 1 and 2 relate to Staphylococcus epidermidis, and Tables 3 to 4 relate to Corynebacterium minutishima.
尚、MBCによって、抗菌力を評価することができる。被験物質の濃度が薄いときには微生物への影響はないが、濃度を増していくと発育抑制が起こり、続いて発育は停止する。更に濃度が増すと、微生物は死滅していくことになる。このときの濃度がMBCとして表される。 The antibacterial activity can be evaluated by MBC. When the test substance concentration is low, there is no effect on microorganisms, but as the concentration is increased, growth inhibition occurs, and then growth stops. As the concentration increases further, the microorganisms will die. The density at this time is expressed as MBC.
表1,3の結果から、アズレンスルホン酸ナトリウム単独(比較例1−1,1−2)では抗菌活性が殆ど認められなかった。また、トリクロサン単独(比較例2−1,2−2)では皮脂成分であるトリオレインの存在により、MBCが12μg/mLから750μg/mLまでに高くなり、抗菌活性が著しく低下することが分かる。これに対して、アズレンスルホン酸ナトリウムとトリクロサンとを併用(実施例1−1,1−2)すると、トレオレイン存在下及び非存在下共に、MBCが著しく低い値となり、両者の抗菌活性が相乗的に著しく増強されることが分かる。 From the results of Tables 1 and 3, almost no antibacterial activity was observed with sodium azulenesulfonate alone (Comparative Examples 1-1 and 1-2). In addition, triclosan alone (Comparative Examples 2-1 and 2-2) shows that MBC increases from 12 μg / mL to 750 μg / mL due to the presence of triolein, which is a sebum component, and the antibacterial activity is significantly reduced. In contrast, when sodium azulenesulfonate and triclosan were used in combination (Examples 1-1 and 1-2), MBC was remarkably low in the presence and absence of treolein, and the antibacterial activities of both were synergistic. It can be seen that it is significantly enhanced.
また、表2,4の結果から、アズレンスルホン酸ナトリウム単独(比較例1−1,1−2)では抗菌活性が殆ど認められなかった。また、IPMP単独(比較例3−1,3−2)では皮脂成分であるトリオレインの存在により、MBCが高くなり、抗菌力が低下することが分かる。これに対して、アズレンスルホン酸ナトリウムとIPMPとを併用(実施例2−1,2−2)すると、トレオレイン存在下及び非存在下共に、MBCが低い値となり、両者の抗菌活性が相乗的に増強されることが分かる。 Moreover, from the results of Tables 2 and 4, almost no antibacterial activity was observed with sodium azulenesulfonate alone (Comparative Examples 1-1 and 1-2). It can also be seen that IPMP alone (Comparative Examples 3-1 and 3-2) increases MBC and reduces antibacterial activity due to the presence of triolein, which is a sebum component. In contrast, when sodium azulenesulfonate and IPMP are used in combination (Examples 2-1 and 2-2), MBC is low in the presence and absence of treolein, and the antibacterial activity of both is synergistic. It can be seen that it is enhanced.
以上、表1〜4の結果から、本発明の抗菌剤組成物は、アズレンスルホン酸ナトリウムと併用することで、汗が多い肌状態でも、皮脂が多い肌状態でも、トリクロサン又はIPMPのそれぞれが本来有する抗菌効果を相乗的に増強し、様々な肌状態で腋臭原因菌に対して優れた抗菌活性を発揮できることが分かる。 As described above, from the results of Tables 1 to 4, the antibacterial agent composition of the present invention was originally used in combination with sodium azulene sulfonate so that each of triclosan or IPMP was originally in a skin state with a lot of sweat or a skin with a lot of sebum. It can be seen that the antibacterial effect possessed can be synergistically enhanced to exhibit excellent antibacterial activity against odor-causing bacteria in various skin conditions.
<試験例2>
(試料の調製)
表5に記した組成に従い、実施例3〜4および比較例4〜6の各防臭剤用組成物を常法により調製し、下記評価に供した。尚、表中の配合量は重量%を表す。
<Test Example 2>
(Sample preparation)
According to the composition described in Table 5, each deodorant composition of Examples 3-4 and Comparative Examples 4-6 was prepared by a conventional method and subjected to the following evaluation. In addition, the compounding quantity in a table | surface represents weight%.
(試験例:防臭剤用組成物の評価)
腋臭が強いと判定された男子被験者10名に、各試料を被験者の一方の腋下に塗布し、もう一方の腋下は比較対照として塗布しなかった。塗布前とその直後及び3時間後のそれぞれについて下記評価基準に従って臭いの判定をし、その平均値を採用した。結果を表5に示す。
(Test example: Evaluation of deodorant composition)
For 10 male subjects determined to have a strong odor, each sample was applied to one armpit of the subject, and the other armpit was not applied as a control. The odor was determined according to the following evaluation criteria before and immediately after application and after 3 hours, and the average value was adopted. The results are shown in Table 5.
<評価基準>
臭わない・・・・・・・・0点
かすかに臭う・・・・・・1点
やや臭うが弱い・・・・・2点
はっきりと臭う・・・・・3点
非常に強く臭う・・・・・4点
<Evaluation criteria>
No odor ... 0 point Slightly smell ... 1 point Slightly weak smell ... 2 points Clear smell ... 3 points Very strong smell ... ... 4 points
表5の結果から、本発明の防臭剤用組成物は優れた防臭効果を有するとともに、その効果も長時間持続することが分かる。 From the results of Table 5, it can be seen that the composition for deodorant of the present invention has an excellent deodorizing effect and the effect also lasts for a long time.
以下、本発明にかかる防臭剤用組成物の処方例を示す。尚、配合量は重量%である。 Hereinafter, the formulation example of the composition for deodorants concerning this invention is shown. In addition, a compounding quantity is weight%.
(処方例1:液体防臭剤)
パラフェノールスルホン酸亜鉛 2.0
エタノール 30.0
1,3−ブチレングリコール 3.0
アズレンスルホン酸ナトリウム 0.1
イソプロピルメチルフェノール 0.1
ポリオキシエチレン(50)硬化ヒマシ油 0.5
香料 適量
精製水 残分
合 計 100.0
(Formulation Example 1: Liquid deodorant)
Zinc paraphenol sulfonate 2.0
Ethanol 30.0
1,3-butylene glycol 3.0
Sodium azulene sulfonate 0.1
Isopropylmethylphenol 0.1
Polyoxyethylene (50) hydrogenated castor oil 0.5
Perfume
Purified water residue Total 100.0
(処方例2:消臭スプレー)
精製水 30.0
エタノール 20.0
アズレンスルホン酸ナトリウム 0.2
イソプロピルメチルフェノール 0.1
ジメチルエーテル 49.7
合 計 100.0
(Formulation example 2: Deodorant spray)
Purified water 30.0
Ethanol 20.0
Sodium azulene sulfonate 0.2
Isopropylmethylphenol 0.1
Dimethyl ether 49.7
Total 100.0
(処方例4:デオドラントスティック)
ステアリルアルコール 25.0
ポリエチレングリコール 10.0
クロロヒドロキシアルミニウム 20.0
環状ジメチルポリシロキサン 44.6
トリクロサン 0.15
アズレンスルホン酸ナトリウム 0.15
香料 0.1
合 計 100.0
(Formulation example 4: Deodorant stick)
Stearyl alcohol 25.0
Polyethylene glycol 10.0
Chlorohydroxyaluminum 20.0
Cyclic dimethylpolysiloxane 44.6
Triclosan 0.15
Sodium azulene sulfonate 0.15
Fragrance 0.1
Total 100.0
(処方例5:デオドラントスティック)
イソプロピルミリスチン酸エステル 10.0
ステアリン酸ナトリウム 10.0
セタノール 3.0
プロピレングリコール 25.0
アズレンスルホン酸ナトリウム 0.2
イソプロピルメチルフェノール 0.1
精製水 1.0
エタノール 残分
香料 適量
合 計 100.0
(Formulation Example 5: Deodorant Stick)
Isopropyl myristic acid ester 10.0
Sodium stearate 10.0
Cetanol 3.0
Propylene glycol 25.0
Sodium azulene sulfonate 0.2
Isopropylmethylphenol 0.1
Purified water 1.0
Ethanol residue
Perfume proper amount total 100.0
(処方例6:ロールオンデオドラント)
エタノール 30.0
ポリオキシエチレン硬化ヒマシ油(40E.O.) 1.0
クロロヒドロキシアルミニウム 10.0
ヒドロキシプロピルメチルセルロース 0.5
トリクロサン 0.1
アズレンスルホン酸ナトリウム 0.1
香料 適量
精製水 残分
合 計 100.0
(Formulation Example 6: Roll-on deodorant)
Ethanol 30.0
Polyoxyethylene hydrogenated castor oil (40E.O.) 1.0
Chlorohydroxyaluminum 10.0
Hydroxypropyl methylcellulose 0.5
Triclosan 0.1
Sodium azulene sulfonate 0.1
Perfume
Purified water residue Total 100.0
(処方例7:デオドラントミスト)
エタノール 45.0
ポリオキシエチレン硬化ヒマシ油(50E.O.) 0.5
パラフェノールスルホン酸亜鉛 0.3
架橋ポリスチレン 5.0
アズレンスルホン酸ナトリウム 0.2
イソプロピルメチルフェノール 0.1
香料 適量
精製水 残分
合計 100.0
(Prescription Example 7: Deodorant Mist)
Ethanol 45.0
Polyoxyethylene hydrogenated castor oil (50E.O.) 0.5
Zinc paraphenol sulfonate 0.3
Cross-linked polystyrene 5.0
Sodium azulene sulfonate 0.2
Isopropylmethylphenol 0.1
Perfume
Purified water Total remaining 100.0
(処方例8:デオドラントジェル)
エタノール 60.0
カルボキシビニルポリマー 0.4
環状シリコーン 1.0
ポリエーテル変性シリコーン 0.5
アズレンスルホン酸ナトリウム 0.1
トリクロサン 0.2
トリエタノールアミン 0.4
シリコーンパウダー 1.0
香料 適量
精製水 残分
合計 100.0
(Prescription Example 8: Deodorant Gel)
Ethanol 60.0
Carboxyvinyl polymer 0.4
Cyclic silicone 1.0
Polyether-modified silicone 0.5
Sodium azulene sulfonate 0.1
Triclosan 0.2
Triethanolamine 0.4
Silicone powder 1.0
Perfume
Purified water Total remaining 100.0
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008068634A JP5025535B2 (en) | 2008-03-18 | 2008-03-18 | Antibacterial agent composition and deodorant composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008068634A JP5025535B2 (en) | 2008-03-18 | 2008-03-18 | Antibacterial agent composition and deodorant composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009221167A JP2009221167A (en) | 2009-10-01 |
| JP5025535B2 true JP5025535B2 (en) | 2012-09-12 |
Family
ID=41238340
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008068634A Expired - Fee Related JP5025535B2 (en) | 2008-03-18 | 2008-03-18 | Antibacterial agent composition and deodorant composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5025535B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105267067A (en) * | 2015-10-16 | 2016-01-27 | 天津市顶硕科贸有限公司 | Skin care cream containing sodium azulene sulfonate |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101999997B (en) * | 2010-11-27 | 2012-08-22 | 天津市顶硕科贸有限公司 | Desensitizing facial mask containing sodium azulene sulfonate |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3178970B2 (en) * | 1994-06-30 | 2001-06-25 | 東レ・ダウコーニング・シリコーン株式会社 | Antiperspirant and deodorant |
| EP0939618B1 (en) * | 1996-07-10 | 2002-09-11 | Steris Inc. | Triclosan skin wash with enhanced efficacy |
| JP2000229826A (en) * | 1999-02-12 | 2000-08-22 | Lion Corp | Antiperspirant composition |
| JP2001089346A (en) * | 1999-09-24 | 2001-04-03 | We'll Corporation:Kk | Oral composition |
| JP2002114670A (en) * | 2000-10-02 | 2002-04-16 | Noevir Co Ltd | Antimicrobial skin care preparation |
| JP2004026721A (en) * | 2002-06-26 | 2004-01-29 | Lion Corp | Hot external preparation composition |
| JP2004203782A (en) * | 2002-12-25 | 2004-07-22 | Kanebo Ltd | Deodorant and antiperspirant external preparation |
| JP4527666B2 (en) * | 2003-08-27 | 2010-08-18 | 株式会社ハニックス | Tooth application composition |
| JP2005160972A (en) * | 2003-11-10 | 2005-06-23 | Rohto Pharmaceut Co Ltd | Container with ophthalmological liquid agent, and ophthalmological liquid agent |
| JP2005232043A (en) * | 2004-02-18 | 2005-09-02 | Gc Corp | Antibacterial dental composition |
| JP2005278428A (en) * | 2004-03-29 | 2005-10-13 | Mitsuo Kitamura | Chewing gum |
| JP4381231B2 (en) * | 2004-06-08 | 2009-12-09 | 株式会社マンダム | Body odor deodorant cosmetic |
| JP2006083111A (en) * | 2004-09-17 | 2006-03-30 | Mandom Corp | Disinfecting composition |
| JP2006096719A (en) * | 2004-09-30 | 2006-04-13 | Mandom Corp | Deodorizing composition and deodorant preparation |
-
2008
- 2008-03-18 JP JP2008068634A patent/JP5025535B2/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105267067A (en) * | 2015-10-16 | 2016-01-27 | 天津市顶硕科贸有限公司 | Skin care cream containing sodium azulene sulfonate |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2009221167A (en) | 2009-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008110999A (en) | Antibacterial composition and deodorant agent | |
| JP6125718B2 (en) | Deodorant composition and deodorant agent | |
| JP6474963B2 (en) | Cleaning composition | |
| JP2003286153A (en) | Skin care composition | |
| JP3908244B2 (en) | Male deodorant deodorant | |
| JP2003081801A (en) | Deodorant cosmetic | |
| JP5275637B2 (en) | Topical skin preparation | |
| JP5522819B2 (en) | Antibacterial composition and external preparation for skin | |
| JP5025535B2 (en) | Antibacterial agent composition and deodorant composition | |
| JP4381231B2 (en) | Body odor deodorant cosmetic | |
| EP2353579A1 (en) | Deodorant composition | |
| JP2007145771A (en) | Antibacterial agent composition and deodorant agent | |
| JP5189402B2 (en) | Antibacterial agent composition and deodorant composition | |
| JP5483820B2 (en) | Antibacterial composition and deodorant | |
| JP6837470B2 (en) | Cleaning composition | |
| JP4743704B2 (en) | Antibacterial agent for bad odor bacteria, anti-odor agent and external preparation for skin containing the antibacterial agent | |
| WO2012131363A2 (en) | Deodorant formulations | |
| JP2006096719A (en) | Deodorizing composition and deodorant preparation | |
| JP5393962B2 (en) | Antibacterial agent for odor-causing bacteria and anti-odor agent containing the antibacterial agent | |
| JPH11286425A (en) | Composition for suppressing aged person smell | |
| JP2007145750A (en) | Antibacterial agent to osmidrosis bacterium, and osmidrosis-preventing agent and external preparation for skin, containing the antibacterial agent | |
| CN117940109A (en) | Composition for preventing bromhidrosis | |
| JP2004067626A (en) | External preparation composition | |
| JP2014205642A (en) | C-S lyase inhibitor | |
| JP2010116376A (en) | Cosmetic |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100915 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20120326 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120424 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120619 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120619 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20180629 Year of fee payment: 6 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5025535 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |